Health & Medical Archives | Be Korea-savvy

Archive by category Health & Medical

Bolder Surgical Announces Global Launch of the CoolSeal™ Vessel Sealing Platform

Bolder Surgical Announces Global Launch of the CoolSeal™ Vessel Sealing Platform

LOUISVILLE, COLORADO, Sept. 22 (Korea Bizwire) – Bolder Surgical today announced the global launch of its CoolSeal™ Vessel Sealing platform. CoolSeal has been in use since October 2020 in the U.S., and with the new international regulatory approvals the devices are available in over 20 countries around the world. Bolder Surgical provides surgeons precision electrosurgical instruments to perform [...]

First-Ever Self-Care Index Assesses Global Readiness to Boost Health System Resilience

First-Ever Self-Care Index Assesses Global Readiness to Boost Health System Resilience

Geneva, Switzerland, Sept. 22 (Korea Bizwire) – The Global Self-Care Federation (GSCF) today announces the launch of a pioneering report for self-care, the Self-Care Readiness Index, developed with the support of the World Health Organization (WHO). The Index identifies four self-care enablers, which offer health systems action-oriented ways to empower individuals, create better health outcomes, and improve health [...]

Eco-Friendly Healthcare Company Dassiet Revolutionises Fracture Treatment with New Product Line UCAST

Eco-Friendly Healthcare Company Dassiet Revolutionises Fracture Treatment with New Product Line UCAST

ESPOO, Finland, Sept. 21 (Korea Bizwire) — Today, the materials company Dassiet is launching UCAST – a product line targeted towards hospitals and health centres, making fracture treatment faster and safer both for the patient and nursing staff. Thermoplastic UCAST cast takes only about 5 minutes to apply, while a traditional cast can take up [...]

CoImmune, Inc. to Participate in Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

CoImmune, Inc. to Participate in Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

DURHAM, N.C., Sept. 20 (Korea Bizwire) — CoImmune, Inc., a clinical stage immuno-oncology company working to redefine cancer treatment using best-in-class cellular immunotherapies, today announced that Charles Nicolette, chief executive officer of CoImmune, will present a corporate update on September 23, 2021 at 9:05AM EDT during the virtual Oppenheimer Fall Healthcare Life Sciences & MedTech [...]

Adagio Therapeutics Provides COVID-19 Antibody Program Updates as well as Business Highlights and Second Quarter 2021 Financial Results

Adagio Therapeutics Provides COVID-19 Antibody Program Updates as well as Business Highlights and Second Quarter 2021 Financial Results

WALTHAM, Mass., Sept. 20 (Korea Bizwire) — Adagio Therapeutics, Inc., (Nasdaq: ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today reported updates on its lead COVID-19 antibody program, ADG20, as well as recent business highlights and second quarter 2021 financial results. “Across [...]

FDA Clears First Technology to Distinguish Between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform

FDA Clears First Technology to Distinguish Between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform

HAIFA, Israel, Boston, MA; Sept. 20 (Korea Bizwire) – MeMed, a leader in the emerging field of advanced host-response technologies, today announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for use of the MeMed BV® test on the point-of-need platform MeMed Key® to help healthcare providers distinguish between bacterial and viral infections. [...]

Junshi Biosciences Announces Expansion of Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Post-Exposure Prophylaxis for COVID-19

Junshi Biosciences Announces Expansion of Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Post-Exposure Prophylaxis for COVID-19

SHANGHAI, China, Sept. 19 (Korea Bizwire) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the United States Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) for etesevimab (JS016/LY-CoV016) 1,400 mg and bamlanivimab (LY-CoV555) 700 [...]

Virgin Pulse Delivers Vaccination Management Solutions to Help Organizations Address and Adhere to New COVID-19 Mandates

Virgin Pulse Delivers Vaccination Management Solutions to Help Organizations Address and Adhere to New COVID-19 Mandates

PROVIDENCE. R.I., Sept. 17 (Korea Bizwire) — In response to the Biden Administration’s recent COVID-19 Action Plan rules and international vaccine regulations and mandates, Virgin Pulse, the leading global provider of tech-enabled health, wellbeing and safety solutions, today announced that it has released new Vaccination Management and Mandate Compliance solutions to help organizations around the world meet evolving mandates [...]

Junshi Biosciences and Coherus to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma

Junshi Biosciences and Coherus to Present Positive Progression Free Survival and Overall Survival Results from JUPITER-06, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma

SHANGHAI, China, and REDWOOD CITY, Calif., Sept. 16 (Korea Bizwire) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) today announced positive interim results from the pivotal study “JUPITER-06” (NCT03829969), a randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating toripalimab in combination with chemotherapy as a first-line [...]

Align Technology Introduces First Professional Whitening System Optimized for Invisalign Aligners and Vivera Retainers Powered by Ultradent’s Opalescence Tooth Whitening Systems

Align Technology Introduces First Professional Whitening System Optimized for Invisalign Aligners and Vivera Retainers Powered by Ultradent’s Opalescence Tooth Whitening Systems

TEMPE, Ariz. and SOUTH JORDAN, Utah, Sept. 16 (Korea Bizwire) — Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced an exclusive supply and distribution agreement [...]